TP53INP1's expression is reduced during the development of breast cancer [39], gastric cancer [40], pancreatic cancer [1] and melanoma [41], but curiously increased in thyroid cancer [42]. The gene discussed is TP53INP1; the disease is familial pancreatic carcinoma.